Physician profile
Pal Singh Randhawa
NPI 1356576839
$10,818.24
in general payments reported to CMS, 2019-2025
23 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $24.12 · 2021: $175 · 2022: $929 · 2023: $991 · 2024: $7,113 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,393 · Food and Beverage: $1,980 · Education: $6.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,392.95 |
| Food and Beverage | $1,980.47 |
| Education | $6.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $6,780.83 | 2021-2025 | Xlif, Reline, Creo 5.5 |
| Spineology INC. | $906.74 | 2022 | |
| Left Coast Surgical INC | $712.68 | 2025 | |
| Nuvasive, INC. | $637.41 | 2023 | Xlif |
| Medtronic, INC. | $372.65 | 2023-2025 | Pipeline, Unid_pass, Mazor X System |
| Stryker Corporation | $277.71 | 2019-2024 | N/A, Airo, Surpass Evolve |
| Arthrex, INC. | $204.95 | 2025 | |
| Cerapedics INC. | $169.75 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Intrinsic Therapeutics | $162.92 | 2021 | |
| Augmedics INC. | $103.56 | 2024 | Xvision |
| Si-Bone, INC. | $86.23 | 2023 | |
| Prosidyan, INC | $50.70 | 2019 | |
| Nevro Corp. | $50.27 | 2019-2020 | |
| Brainlab, INC. | $47.46 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Alphatec Spine, INC | $47.17 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $46.00 | 2019 | |
| Providence Medical Technology, INC. | $36.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.79 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $22.39 | 2024 | Spine & Trauma 3d Navigation, Symphony, Teligen |
| Convatec INC. | $22.32 | 2022 | |
| Portola Pharmaceuticals, LLC | $19.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pal Randhawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.